The Eventide Exponential Technologies Fund Class N (ticker: ETNEX) is a specialized investment fund primarily focused on exposure to innovative technologies and exponential growth companies. The fund invests in a diversified portfolio of equities within sectors such as technology, healthcare, and industrials, targeting firms involved in cutting-edge developments including artificial intelligence, advanced computing, robotics, and biotechnology. Its core products include managed equity fund shares aimed at institutional and retail investors seeking growth through technological innovation.
The fund is part of Eventide Asset Management, founded in 2002 and headquartered in Boston, Massachusetts. Eventide emphasizes investments aligned with positive social impact and long-term growth. In recent major developments, the fund has expanded its portfolio through strategic partnerships with technology firms to better access emerging market leaders and has launched new share classes to broaden investor access. It has also increased its focus on sustainability and ethical investment criteria as part of its strategic evolution over the past two years.
Eventide operates primarily in the United States but invests globally across major developed and emerging markets. The fund’s management team combines financial expertise with deep technology sector insights, positioning ETNEX as a comprehensive channel for investors aiming to capture value in the accelerating field of exponential technologies. The fund’s ongoing initiatives include enhanced research capabilities and collaboration with technology innovators to maintain a competitive edge in portfolio construction and risk management.